What we know about ocular manifestations of Ebola

Majid Moshirfar,1 Carlton R Fenzl,2 Zhan Li3 1Department of Ophthalmology, Francis I Proctor Foundation, University of California San Francisco, San Francisco, CA, USA; 2John A Moran Eye Center, University of Utah, Salt Lake City, UT, USA; 3University of Nevada School of Medicine,...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Moshirfar M, Fenzl CR, Li Z
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2014
Materias:	Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/89d1dea4a7034df2b8c52a176fcff283
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:89d1dea4a7034df2b8c52a176fcff283
record_format	dspace
spelling	oai:doaj.org-article:89d1dea4a7034df2b8c52a176fcff2832021-12-02T05:59:33ZWhat we know about ocular manifestations of Ebola1177-5483https://doaj.org/article/89d1dea4a7034df2b8c52a176fcff2832014-11-01T00:00:00Zhttp://www.dovepress.com/what-we-know-about-ocular-manifestations-ofnbspebola-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483 Majid Moshirfar,1 Carlton R Fenzl,2 Zhan Li3 1Department of Ophthalmology, Francis I Proctor Foundation, University of California San Francisco, San Francisco, CA, USA; 2John A Moran Eye Center, University of Utah, Salt Lake City, UT, USA; 3University of Nevada School of Medicine, Reno, NV, USA Abstract: Ebola hemorrhagic fever is a deadly disease caused by several species of ebolavirus. The current outbreak of 2014 is unique in that it has affected a greater number of people than ever before. It also has an unusual geographic distribution. Nonspecific findings such as fever and generalized weakness have traditionally been very common early in the acute phase. Ophthalmic manifestations have also been reported in significant numbers. Conjunctival injection has been identified in both the acute and late phases. Subconjunctival hemorrhage and excessive lacrimation have also been reported. Various forms of uveitis have been associated with the convalescent phase of the disease. When identified in conjunction with other signs such as fever, acute findings such as conjunctivitis may contribute to the diagnosis of Ebola hemorrhagic fever. Ideally, serologic testing should be performed prior to isolation and treatment of these individuals. Considering the prevalence of the current outbreak and the threat of transcontinental spread, ophthalmic health professionals need to be aware of the ocular manifestations of Ebola hemorrhagic fever as well as the associated signs and symptoms in order to prevent further spread. Keywords: conjunctivitis, ebolavirus, subconjunctival hemorrhage, uveitis, Ebola hemorrhagic feverMoshirfar MFenzl CRLi ZDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2014, Iss default, Pp 2355-2357 (2014)
institution	DOAJ
collection	DOAJ
language	EN
topic	Ophthalmology RE1-994
spellingShingle	Ophthalmology RE1-994 Moshirfar M Fenzl CR Li Z What we know about ocular manifestations of Ebola
description	Majid Moshirfar,1 Carlton R Fenzl,2 Zhan Li3 1Department of Ophthalmology, Francis I Proctor Foundation, University of California San Francisco, San Francisco, CA, USA; 2John A Moran Eye Center, University of Utah, Salt Lake City, UT, USA; 3University of Nevada School of Medicine, Reno, NV, USA Abstract: Ebola hemorrhagic fever is a deadly disease caused by several species of ebolavirus. The current outbreak of 2014 is unique in that it has affected a greater number of people than ever before. It also has an unusual geographic distribution. Nonspecific findings such as fever and generalized weakness have traditionally been very common early in the acute phase. Ophthalmic manifestations have also been reported in significant numbers. Conjunctival injection has been identified in both the acute and late phases. Subconjunctival hemorrhage and excessive lacrimation have also been reported. Various forms of uveitis have been associated with the convalescent phase of the disease. When identified in conjunction with other signs such as fever, acute findings such as conjunctivitis may contribute to the diagnosis of Ebola hemorrhagic fever. Ideally, serologic testing should be performed prior to isolation and treatment of these individuals. Considering the prevalence of the current outbreak and the threat of transcontinental spread, ophthalmic health professionals need to be aware of the ocular manifestations of Ebola hemorrhagic fever as well as the associated signs and symptoms in order to prevent further spread. Keywords: conjunctivitis, ebolavirus, subconjunctival hemorrhage, uveitis, Ebola hemorrhagic fever
format	article
author	Moshirfar M Fenzl CR Li Z
author_facet	Moshirfar M Fenzl CR Li Z
author_sort	Moshirfar M
title	What we know about ocular manifestations of Ebola
title_short	What we know about ocular manifestations of Ebola
title_full	What we know about ocular manifestations of Ebola
title_fullStr	What we know about ocular manifestations of Ebola
title_full_unstemmed	What we know about ocular manifestations of Ebola
title_sort	what we know about ocular manifestations of ebola
publisher	Dove Medical Press
publishDate	2014
url	https://doaj.org/article/89d1dea4a7034df2b8c52a176fcff283
work_keys_str_mv	AT moshirfarm whatweknowaboutocularmanifestationsofnbspebola AT fenzlcr whatweknowaboutocularmanifestationsofnbspebola AT liz whatweknowaboutocularmanifestationsofnbspebola
_version_	1718400119974395904

What we know about ocular manifestations of&nbsp;Ebola

Ejemplares similares

What we know about ocular manifestations of Ebola